Topic: Bone disorders

Researchers advise annual screening for tumours in children with mutations in the SDHB gene, starting from the age of 5 years.

Burosumab treatment improves rickets and prevents decline in growth in young children with X-linked hypophosphataemia, show the findings of an open-label phase II study.